IGC Pharma, Inc. (NYSE:IGC) has 30 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| LAWOOD & CO | 31 Dec, 2025 | 0 | 75,000 | 0.00% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -299,324 | -24.56% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 28,324 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 8,033 | 0.94% | $0.00 |
| T3 Companies, LLC | 31 Dec, 2025 | 0 | 20,000 | 0.00% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | -350,246 | -55.79% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 16,824 | 552.51% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 40,592 | 25.34% | $0.00 |
| Geneos Wealth Management Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 0 | 140,997 | 1,009.86% | $0.00 |
| Caitlin John, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Northern Trust Corp | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Farther Finance Advisors, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Hurley Capital, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Root Financial Partners, LLC | 31 Dec, 2025 | 0 | 100 | 0.00% | $0.00 |
| DEARBORN PARTNERS LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| DHJJ Financial Advisors, Ltd. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |